Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
Nanni C, Castellucci P, Farsad M, Pinto C, Moretti A, Pettinato C, Marengo M, Boschi S, Franchi R, Martoni A, Monetti N, Fanti S.
Nanni C, et al.
Cancer Biother Radiopharm. 2004 Apr;19(2):149-54. doi: 10.1089/108497804323071913.
Cancer Biother Radiopharm. 2004.
PMID: 15186594
Clinical Trial.